Benitec Biopharma (BNTC) Change in Receivables (2019 - 2025)
Benitec Biopharma (BNTC) reported Change in Receivables of -$123000.0 for Q4 2025, down 154.42% on a YoY basis from $226000.0 in Q4 2024, and down 310.0% sequentially from -$30000.0 in Q3 2025.
Benitec Biopharma (BNTC) Change in Receivables (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 6 years of Change in Receivables data on file, last reported at -$123000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables fell 154.42% year-over-year to -$123000.0; the trailing twelve-month figure through Dec 2025 stood at -$350000.0 (down 298.86% YoY), and the FY2025 full-year result was -$197000.0, down 211.93% from the prior year.
- Change in Receivables retreated to -$123000.0 in Q4 2025, from -$30000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $226000.0 in Q4 2024 to a low of -$226000.0 in Q3 2024.
- A 4-year average of -$15909.1 and a median of -$7000.0 in 2021 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 757.14% in 2022, while the deepest fall reached 771.43% in 2022.
- Tracing BNTC's Change in Receivables over 4 years: stood at -$7000.0 in 2021, then surged by 757.14% to $46000.0 in 2022, then surged by 391.3% to $226000.0 in 2024, then tumbled by 154.42% to -$123000.0 in 2025.
- Business Quant data shows BNTC's Change in Receivables at -$123000.0 in Q4 2025, -$30000.0 in Q3 2025, and $29000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | -123,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -123,000.00 |
| Dec 31, 2025 | -123,000.00 |
| Sep 30, 2025 | -30,000.00 |
| Sep 30, 2025 | -30,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | -226,000.00 |
| Mar 31, 2025 | -226,000.00 |
| Dec 31, 2024 | 226,000.00 |
| Dec 31, 2024 | 226,000.00 |
| Sep 30, 2024 | -226,000.00 |
| Sep 30, 2024 | -226,000.00 |
| Jun 30, 2024 | 176,000.00 |
| Jun 30, 2024 | 176,000.00 |
| Jun 30, 2022 | 46,000.00 |
| Jun 30, 2022 | 46,000.00 |
| Mar 31, 2022 | -47,000.00 |
| Mar 31, 2022 | -47,000.00 |
| Jun 30, 2021 | -7,000.00 |
| Jun 30, 2021 | -7,000.00 |